Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001628280-25-045222
Filing Date
2025-10-16
Accepted
2025-10-16 16:32:18
Documents
15
Period of Report
2025-07-31
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mnk-20250731.htm   iXBRL 8-K/A 32820
2 EX-23.1 ex231pwcconsentendoinc.htm EX-23.1 2417
3 EX-23.2 ex232pwcconsentendoplc.htm EX-23.2 1953
4 EX-99.3 mnkproformasalvare2025q2.htm EX-99.3 747226
  Complete submission text file 0001628280-25-045222.txt   968454

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mnk-20250731.xsd EX-101.SCH 2164
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mnk-20250731_lab.xml EX-101.LAB 22462
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mnk-20250731_pre.xml EX-101.PRE 13154
18 EXTRACTED XBRL INSTANCE DOCUMENT mnk-20250731_htm.xml XML 2710
Mailing Address COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN DUBLIN 15 Ireland D15
Business Address COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN DUBLIN 15 Ireland D15 353 1 6960000
Mallinckrodt plc (Filer) CIK: 0001567892 (see all company filings)

EIN.: 981088325 | State of Incorp.: L2 | Fiscal Year End: 1226
Type: 8-K/A | Act: 34 | File No.: 001-35803 | Film No.: 251398020
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)